U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Scientist
  6. National Center for Toxicological Research
  7. Science & Research (NCTR)
  8. NCTR Publications
  9. NCTR COVID-19/SARS-CoV-2 Publications
  1. NCTR Publications

NCTR COVID-19/SARS-CoV-2 Publications

*As of 12/1/2022

Published in FY2023
“Enhanced Virulence and Waning Vaccine-Elicited Antibodies Account for SARS-CoV-2 Delta and Kappa Breakthrough Infections in K18-hACE2 Passive Transfer Model.” iScience (December 2022).
"Temporal Dynamics of SARS-CoV-2 Genome and Detection of Variants of Concern in Wastewater Influent from Two Metropolitan Areas in Arkansas.” Science of the Total Environment (November 2022).
“Applying Imaging Mass Spectrometry to Define the N-glycan Profiles of Co-localized Virus and Immune Cell Infiltrates in Post-COVID-19 Infected Lung Autopsy Tissues.” Frontiers in Analytical Science (October 2022).

 

Published in FY2022
“Evaluation of the Mutagenic Effects of Molnupiravir and N4-hydroxycytidine in Bacterial and Mammalian Cell by HiFi Sequencing.” Environmental and Molecular Mutagenesis (August 2022).
"NeuroCORD: A Language Model to Facilitate COVID-19-Associated Neurological Disorder Studies."  International Journal of Environmental Research and Public Health (August 2022).
“AI-Powered Drug Repurposing for Developing COVID-19 Treatments.” Reference Module in Biomedical Sciences (January 2022). 
“AI-Based Language Models Powering Drug Discovery and Development.” Drug Discovery Today (November 2021).

 

Published in FY2021
"Biochemical Features and Mutations of Key Proteins in SARS-CoV-2 and Their Impacts on RNA Therapeutics." Biochemical Pharmacology (July 2021).
"Can SARS-CoV-2 Infect the Central Nervous System via the Olfactory Bulb or the Blood-Brain Barrier?" Brain, Behavior, and Immunity (July 2021). 
"Informing Selection of Drugs for COVID-19 Treatment Through Adverse Events Analysis." Scientific Reports (July 2021).
"Identification of Epidemiological Traits by Analysis of SARS-CoV-2 Sequences." Viruses (May 2021).
"Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data." Frontiers in Artificial Intelligence (March 2021).
"Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations." Frontiers in Chemistry (January 2021).
"Pericytes Within a Pulmonary Neurovascular Unit in COVID-19-elicited Pathologic Changes." Current Neurovascular Research (December 2020).
"FDALabel for Drug Repurposing Studies and Beyond." Nature Biotechnology (December 2020).

 

Back to Top